v3.25.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2025
Segment Information  
Schedule of segment's loss, including significant segment expenses

Three Months Ended March 31, 

(In thousands)

  

2025

  

2024

Total revenue

$

15,388

$

14,503

Employee-related (Research and development) 1

3,931

3,305

External-related (Research and development)

 

5,565

 

3,377

Facilities and other allocated expenses (Research and development)

 

886

 

821

Supporting general and administration functions 1

7,258

6,921

Sales and marketing, and medical affairs 1

7,305

6,057

Share-based compensation

 

4,877

 

5,229

Total operating expenses

29,822

25,710

Loss from operations

(14,434)

(11,207)

Interest expense (non-cash)

(643)

(629)

Interest and other income, net

939

1,434

Provision for income tax benefit (expense)

559

(1,262)

Net loss

$

(13,579)

$

(11,664)

1 Excludes share-based compensation